• The Joint Corp. swung to net income of $1.1 million as revenue rose 13.3% to $14.82 million.
• Operating income totaled $873,668, reversing an operating loss in the prior-year quarter.
• System-wide sales fell 4.9% to $126.1 million, while comp sales declined 4.2%.
• Clinic count reached 943 at March 31 with 868 franchised units; franchisees opened three clinics, while franchise license sales totaled no licenses.
• Repurchased 137,088 shares for about $1.1 million, leaving $4.5 million authorized under the 2025 stock repurchase program.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Joint Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001612630-26-000051), on May 08, 2026, and is solely responsible for the information contained therein.